However, TRF (60 and 120 mg/kg) treatments in T2DM rats attenuated the increased AChE activity and improved the cholinergic functioning, and protected the cognitive impairment, perhaps by inhibiting AChE activity and increasing ACh concentration. The gene discussed is ACHE; the disease is type 2 diabetes mellitus.